An update on cutaneous vascular tumours

Published:November 05, 2021DOI:https://doi.org/10.1016/j.mpdhp.2021.10.003

      Abstract

      The classification of vascular lesions is complex. There is a slight overlap between reactive, developmental and benign vascular tumours, and some conditions defy precise classification. This review follows the most recent World Health Organization (WHO) classification of cutaneous vascular tumors and provides the framework for a systematic study, incorporating as many recent advances in molecular and immunohistochemical diagnostics as possible at this moment in time.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Diagnostic Histopathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Calonje J.E. Brenn T. Lazar A.J. Billings S.D. McKee's pathology of the skin. 5th Edn. Elsevier, Amsterdam2018
        • Boon L.M.
        • Enjolras O.
        • Mulliken J.B.
        Congenital hemangioma: evidence for accelerated involution.
        J Pediatr. 1996; 128: 329-335
        • Ayturk U.M.
        • Couto J.A.
        • Hann S.
        • et al.
        Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma.
        Am J Hum Genet. 2016; 98: 789-795
        • Léauté-Labrèze C.
        • Harper J.I.
        • Hoeger P.H.
        Infantile haemangioma.
        Lancet. 2017; 390: 85-94
        • Calonje E.
        • Mentzel T.
        • Fletcher C.D.M.
        Pseudosarcomatous neural invasion in capillary hemangiomas.
        Histopathology. 1995; 26: 159-164
        • Liau J.Y.
        • Lee J.C.
        • Tsai J.H.
        • et al.
        High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.
        Mod Pathol. 2019; 32: 1657-1665
        • Wilson Jones E.
        • Orkin M.
        Tufted angioma (angioblastoma): a benign progressive angioma, not to be confused with Kaposi's sarcoma or low-grade angiosarcoma.
        J Am Acad Dermatol. 1989; 20: 214-225
        • Lim Y.H.
        • Bacchiocchi A.
        • Qiu J.
        • et al.
        GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation.
        Am J Hum Genet. 2016; 99: 443-450
        • Groesser L.
        • Peterhof E.
        • Evert M.
        • Landthaler M.
        • Berneburg M.
        • Hafner C.
        BRAF and RAS mutations in sporadic and secondary pyogenic granuloma.
        J Invest Dermatol. 2016; 136: 481-486
        • Calonje E.
        • Fletcher C.D.M.
        Sinusoidal hemangioma: a distinctive benign vascular neoplasm within the group of cavernous hemangiomas.
        Am J Surg Pathol. 1991; 15: 1130-1135
        • Semkova K.
        • Carr R.
        • Grainger M.
        • et al.
        Poikilodermatous plaque-like hemangioma: case series of a newly defined entity.
        J Am Acad Dermatol. 2019; 81: 1257-1270
        • Goh N.
        • Dayrit J.
        • Calonje E.
        Symplastic hemangioma: report of two cases.
        J Cutan Pathol. 2006; 33: 735-740
        • Brenn T.
        • Fletcher C.D.M.
        Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors.
        Am J Dermatopathol. 2004; 26: 14-21
        • Luzar B.
        • Ieremia E.
        • Antonescu C.R.
        • Zhang L.
        • Calonje E.
        Cutaneous intravascular epithelioid hemangioma. A clinicopathological and molecular study of 21 cases.
        Mod Pathol. 2020; 33: 1527-1536
        • Huang S.C.
        • Zhang L.
        • Sung Y.S.
        • et al.
        Frequent FOS gene rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal.
        Am J Surg Pathol. 2015; 39: 1313-1321
        • Tsuda Y.
        • Suurmeijer A.J.H.
        • Sung Y.S.
        • Zhang L.
        • Healey J.H.
        • Antonescu C.R.
        Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: a clinicopathologic and molecular study.
        Genes Chromosomes Cancer. 2021; 60: 17-25
        • Antonescu C.R.
        • Huang S.C.
        • Sung Y.S.
        • et al.
        Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma.
        Mod Pathol. 2021; 34: 934-941
        • Ortins-Pina A.
        • Llamas-Velasco M.
        • Turpin S.
        • Soares-de-Almeida L.
        • Filipe P.
        • Kutzner H.
        FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia).
        J Cutan Pathol. 2018; 45: 395-402
        • Chong H.
        • Brady K.
        • Metze D.
        • Calonje E.
        Persistent nodules at injection sites (aluminium granuloma) -- clinicopathological study of 14 cases with a diverse range of histological reaction patterns.
        Histopathology. 2006; 48: 182-188
        • Kurek K.C.
        • Pansuriya T.C.
        • van Ruler M.A.
        • et al.
        R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations.
        Am J Pathol. 2013; 183: 1494-1500
        • Brenn T.
        • Fletcher C.D.
        Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
        Am J Surg Pathol. 2005; 29: 983-996
        • Corradini A.G.
        • Asioli S.
        • Morandi L.
        • et al.
        Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
        Histopathology. 2020; 77: 293-302
        • Guo T.
        • Zhang L.
        • Chang N.E.
        • Singer S.
        • Maki R.G.
        • Antonescu C.R.
        Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
        Genes Chromosomes Cancer. 2011; 50: 25-33
        • Ten Broek R.W.
        • Koelsche C.
        • Eijkelenboom A.
        • et al.
        Kaposiform hemangioendothelioma and tufted angioma - (epi)genetic analysis including genome-wide methylation profiling.
        Ann Diagn Pathol. 2020; 44: 151434
        • Calonje E.
        • Fletcher C.D.M.
        • Wilson Jones E.
        • Rosai J.
        Retiform hemangioendothelioma: a distinctive form of low-grade angiosarcoma delineated in a series of 15 cases.
        Am J Surg Pathol. 1994; 18: 115-125
        • Antonescu C.R.
        • Dickson B.C.
        • Sung Y.S.
        • et al.
        Recurrent YAP1 and MAML2 gene rearrangements in retiform and composite hemangioendothelioma.
        Am J Surg Pathol. 2020; 44: 1677-1684
        • Billings S.D.
        • Folpe A.L.
        • Weiss S.W.
        Epithelioid sarcoma-like hemangioendothelioma.
        Am J Surg Pathol. 2003; 27: 48-57
        • Hornick J.L.
        • Fletcher C.D.
        Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
        Am J Surg Pathol. 2011; 35: 190-201
        • Hung Y.P.
        • Fletcher C.D.
        • Hornick J.L.
        FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma.
        Am J Surg Pathol. 2017; 41: 596-606
        • Walther C.
        • Tayebwa J.
        • Lilljebjorn H.
        • et al.
        A novel SERPINE1-FOSB fusion gene results in a transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
        J Pathol. 2014; 232: 534-540
        • Nayler S.J.
        • Rubin B.P.
        • Calonje E.
        • Chan J.K.
        • Fletcher C.D.
        Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma.
        Am J Surg Pathol. 2000; 24: 352-361
        • Perry K.D.
        • Al-Lbraheemi A.
        • Rubin B.P.
        • et al.
        Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.
        Mod Pathol. 2017; 30: 1589-1602
        • Mentzel T.
        • Beham A.
        • Calonje E.
        • Katenkamp D.
        • Fletcher C.D.
        Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases.
        Am J Surg Pathol. 1997; 21: 363-374
        • Shibayama T.
        • Makise N.
        • Motoi T.
        • et al.
        Clinicopathologic characterization of epithelioid hemangioendothelioma in a series of 62 cases: a proposal of risk stratification and identification of a synaptophysin-positive aggressive subset.
        Am J Surg Pathol. 2021; 45: 616-626
        • Tanas M.R.
        • Sboner A.
        • Oliveira A.M.
        • et al.
        Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
        Sci Transl Med. 2011; 398ra82
        • Antonescu C.R.
        • Le Loarer F.
        • Mosquera J.M.
        • et al.
        Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
        Genes Chromosomes Cancer. 2013; 52: 775-784
        • Doyle L.A.
        • Fletcher C.D.
        • Hornick J.L.
        Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics.
        Am J Surg Pathol. 2016; 40: 94-102
        • Young R.J.
        • Brown N.J.
        • Reed M.W.
        • Hughes D.
        • Woll P.J.
        Angiosarcoma.
        Lancet Oncol. 2010; 11: 983-991
        • Cui L.
        • Zhang J.
        • Zhang X.
        Angiosarcoma (Stewart-Treves syndrome) in postmastectomy patients: report of 10 cases and review of literature.
        Int J Clin Exp Pathol. 2015; 8: 11108-11115
        • Cohen-Hallaleh R.B.
        • Smith H.G.
        • Smith R.C.
        • et al.
        Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series.
        Clin Sarcoma Res. 2017; 7: 15
        • Suchak R.
        • Thway K.
        • Zelger B.
        • Fisher C.
        • Calonje E.
        Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
        Am J Surg Pathol. 2011; 35: 60-69
        • Mentzel T.
        • Schildhaus H.U.
        • Palmedo G.
        • Büttner R.
        • Kutzner H.
        Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
        Mod Pathol. 2012; 25: 75-85
        • Huang S.C.
        • Zhang L.
        • Sung Y.S.
        • et al.
        Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations.
        Am J Surg Pathol. 2016; 40: 645-655